InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2023-03-31 00:00:00 ET · period of report 2023-03-29 · accession 0001415889-23-005666 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-31 2023-03-29 PTCT Utter Christine Marie SVP, CAO, Fin S - Sale+OE $47.79 -4,688 38.1K -11% -$224.1K
D 2023-03-31 2023-03-29 PTCT Utter Christine Marie SVP, CAO, Fin M - OptEx $40.45 +4,688 42.7K +12% +$189.6K
D 2023-03-31 2023-03-29 PTCT Utter Christine Marie SVP, CAO, Fin M - OptEx $40.45 -4,688 0 -100% -$189.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-29 S D 3,247 $47.80 39,500 D — — (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.50 to $48.285 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2023-03-29 M A 4,688 $40.45 42,747 D — —
3 Common Common Stock 2023-03-29 S D 1,441 $47.78 38,059 D — — (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.50 to $48.285 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (Right to Buy) 2023-03-29 M D 4,688 $40.45 0 D $40.45 · — to 2024-09-23 4,688 Common Stock (F3) Currently exercisable.